Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T14:57:03.209Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T14:57:03.209Z.
Quote observation: 2026-10-06T14:46:31.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6ebeba272bae7de15d59b23151f0025007a9c632b25eeddd13cd9ab927e6ebe5
FORWARD PE RATIO
N/A
Gelteq Limited Ordinary Shares
Market Cap
$5.17M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Gelteq Limited Ordinary Shares (GELS) | $5.17M | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.17M | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.20M | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | N/A |
| Imunon, Inc. (IMNN)vs › | $4.99M | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.54M | N/A |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.79M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
Consensus estimates for this stock are reported in AUD, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
